Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RelB regulates human dendritic cell subset development by promoting monocyte intermediates.

Barbara Platzer1, Almut Jörgl, Sabine Taschner

  • 1Institute of Immunology, University of Vienna, A-1235, Brunnerstrasse 59, Vienna, Austria.

Blood
|August 19, 2004
PubMed
Summary

The transcription factor RelB controls the development of specific dendritic cell (DC) subsets from human myeloid progenitors. RelB inhibition blocks monocyte-derived DC precursor development, impacting monopoiesis and DC subset differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of Noninvasive Cutaneous Carotenoid Measurements as Nutritional Biomarker Across Body Composition Groups.

Food science & nutrition·2026
Same author

Comparative Evaluation of a Nanocellulose Hydrogel and Matrigel<sup>®</sup> in a Vascularized Intestinal-CAM Model.

Gels (Basel, Switzerland)·2026
Same author

Human epidermal Langerhans cells induce tolerance and hamper T cell function upon tick-borne pathogen transmission.

Nature communications·2025
Same author

Retinoic Acid Modulates Immune Differentiation in a Human Small Intestinal In Vitro Model.

Cells·2025
Same author

Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation.

Nature communications·2025
Same author

Vitamin K supports TGF-β1 depended <i>in vitro</i> human Langerhans cell differentiation and function via Axl.

Frontiers in immunology·2025

Area of Science:

  • Immunology
  • Cell Biology
  • Hematopoiesis

Background:

  • Human myeloid dendritic cells (DCs) comprise epithelial Langerhans cells (LCs) and interstitial DCs.
  • The molecular mechanisms governing the development of these DC subsets from common myeloid progenitors are not well understood.

Purpose of the Study:

  • To investigate the role of the nuclear factor-kappaB (NF-kappaB) transcription factor RelB in the development of human myeloid DC subsets.
  • To elucidate the specific stages of hematopoietic progenitor development regulated by RelB.

Main Methods:

  • Analysis of RelB function in human hematopoietic progenitors using overexpression and inhibition (p100DeltaN).
  • Flow cytometry to assess cell surface markers (CD14, CD11b) and differentiation potential.
  • Comparison of RelB inhibition with classical NF-kappaB signaling inhibition (IkappaBalpha-SR).

Related Experiment Videos

Main Results:

  • RelB overexpression promoted, while RelB inhibition blocked, the development of monocytic CD14(+)CD11b(+) precursors for interstitial DCs.
  • RelB inhibition specifically arrested precursor progression from CD14(lo)CD11b(-) to CD14(+)CD11b(+) stages.
  • RelB inhibition impaired M-CSF-dependent monocyte/macrophage differentiation but not LC or granulocyte differentiation; it differed from IkappaBalpha-SR effects on DC differentiation, adhesion, and proliferation.

Conclusions:

  • RelB plays a critical role in regulating human monopoiesis and the development of monocyte-derived DC subsets.
  • RelB's function in DC subset development is distinct from its role in DC maturation, as ectopic RelB overexpression did not promote maturation.